Dr. Cheryl Wellington is Professor in the Department of Pathology and Laboratory Medicine, Djavad Mowafaghian Center for Brain Health at the University of British Columbia. She is also Principal Investigator at the International Collaboration on Repair Discoveries at Vancouver General Hospital and Associate Member of the UBC School of Biomedical Engineering. Dr. Wellington’s research interests are highly multipdisciplinary with major efforts in the fields of Alzheimer’s Disease (AD) and Traumatic Brain Injury (TBI). With respect to both AD and TBI programs, her laboratory is the leading Canadian site for research on blood biomarkers using the Quanterix single molecule array (Simoa) platform. Her work on AD focuses mainly on how lipoproteins affect AD pathogenesis, with major projects focused on apolipoprotein E (apoE). For the AD program, her laboratory uses a combination of animal models and in vitro platforms, including pioneering a human-based 3D tissue engineered model of perfusable cerebral vessels surrounded by astrocytes and neurons. Along with Dr. Peter Cripton, a Mechanical Engineer, Dr. Wellington developed the CHIMERA (Closed Head Model of Engineered Rotational Acceleration) animal model of TBI that is currently operational for mice, rats and ferrets. Dr. Wellington holds multiple leadership positions in both the dementia and neurotrauma communities, including the Canadian Traumatic Brain Injury Research Consortium, the International Traumatic Brain Injury Research Consortium, the Canadian Consortium for Neurodegeneration in Aging, and Cure Alzheimer Fund ApoE Consortium.